Spring direct naar de hoofdnavigatie of de inhoud
‘In the end it's all about the value that the patent adds to the product.’
Mark Einerhand

Mark Einerhand

  • Life Sciences
  • European and Dutch Patent Attorney
  • Partner

Mark Einerhand has been active in the patent world since 1998, when he made the switch from a biotech startup to V.O.

Mark’s career started in science. After his studies of molecular biology at the University of Amsterdam, he took his PhD in medical science inLeiden, in 1992. He was a visiting scientist at Cornell University in New York and the MRC at Mill Hill in London.

Continue reading

His particular expertise lies in the field of medical (bio)technology, diagnostics and medicines. Because of his background at Introgene/Crucell, Mark has a special affinity with Life Science startups. He has a wide experience in patent cases before the court in The Hague.

Working experience

  • Patent Attorney, V.O. (1998-present)
  • IntroGene (now Crucell), Rijswijk (1995)
  • Post-Doc at Leiden University (1993)
  • Medical Research Council, Mill Hill, London (1992)
  • Visiting Scientist, Cornell University New York (1992)

Education

  • PhD in Medicine, Leiden University (1992)
  • MSc in Biochemistry, University of Amsterdam (1987), Major in Molecular Oncology, Dutch Cancer Institute

Publications

  • Co-author of article ‘The patentability of stem cells in Europe’, IAM Life Sciences 2015.
    Einerhand, M.P.W. (2011): Advance offering of generics found to infringe. Managing Intellectual Property: Vol 205: page: 87.
  • Einerhand M.P.W. (2010): A contribution to: Legal and intellectual property issues associated with stem cells. In: Stem Cells; scientific facts and fiction, (C. Mummery; I. Wilnut, A van de Stolpe and
    B.A.J. Roelen), Academic Press: Elsevier.
  • Einerhand M.P.W. and van Melle, J (2004): Patenting of inventions in the field of bio-informatics.
    In: The new avenues in Bioinformatics, (Seckbach, J and Rubin, E eds), Kluwer Academic Publishers, the Netherlands.
  • Principle inventor on Patents and Patent Applications: Einerhand, M.P.W. and Valerio (1997). WO 98/32870: US 6,232,105: A conditional replication and expression system. Einerhand, M.P.W. and Valerio (1997). WO 99/32647: Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into chromosomal DNA of target cells in gene therapy. Einerhand, M.P.W. and Valerio (1996). WO98/24924: NZ 336185:
  • Transduction of primate hemopoietic repopulating stem cells. Einerhand, M.P.W. and Valerio (1995). WO 97/20943: US 6,140,103: Regulated protein expression in stably transfected mammalian cells. Einerhand, M.P.W. (1992) Gene transfer into hemopoietic stem cells: prospects for human gene therapy. University of Leiden.

Professional & Community Activities

  • Member of the Steering Committee World IP Forum 2015
    Former member of the European Qualifying Examination committee III

Languages

  • English
  • Dutch
  • German

News

Recommended by JUVE Patent

In May 2020, V.O. was recommended by JUVE Patent in the categories Patent Filing and Prosecution. Listed as recommended individuals are Marco Box, Leo Jessen, Bernard Ledeboer, Otto Oudshoorn and Jetze Beeksma.Continue reading

Two prizes for V.O.

This January, the Netherlands’ office of V.O. was crowned the best patent firm of 2019. This selection as the ‘Netherlands Patent Attorney Firm of the Year’ was announced by the Intellectual Asset Management (IAM) and World Trademark Review (WTR).Continue reading

The utility model – a rapid alternative to a patent

A patent application is often the solution for anyone who wishes to officially attach exclusive rights to intellectual property. However, there are alternatives. For instance, in the German market, companies can also choose to protect industrial inventions using a ‘utility model’.Continue reading

Events

Knowledge for Growth 2020

Gent ICC, Ghent, Belgium

Don’t miss the 2020 edition on 10 September and capture the attention of 1,200 high-level life sciences actors from about 550 companies & organisations! The cream of the European life sciences community will be attending the 16th edition of flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech as well as investors, universities, topnotch research institutes, policymakers and competence providers. Continue reading

IPBC Europe 2020

Shelbourne Hotel, Saint Stephen's Green, Dublin, Ireland

Europe’s foremost conference about IP value creation. On 19-21 October, the prestigious Shelbourne Hotel will play host to corporate IP leaders from across Europe and beyond when they meet to discuss what world-class IP portfolios, strategies and service provision look like – and how to achieve them. Continue reading

Sustainable Plastics & Materials Expo 2020

ATLAS Theater, Raadhuisplein 100, Emmen, Netherlands

The first edition of the Sustainable Plastics & Materials Expo 2020 will take place in Chemical Cluster Emmen in the Netherlands. Continue reading